WHO Ends Trial Of Chloroquine As Treatment For COVID-19

Pinterest LinkedIn Tumblr

The World Health Organisation has stopped the trial of Hydroxychloroquine as a treatment for .

WHO Ends Trial Of Chloroquine As Treatment For COVID-19
Ends Trial Of As Treatment For COVID-19

WHO said evidence has shown that hydroxychloroquine, an anti-malaria drug, does not reduce the mortality rate of COVID-19.

“The Solidarity Trial’s hydroxychloroquine arm is being stopped, on the basis of evidence showing it does not reduce mortality for hospitalised #COVID19 patients,” it said.

The agency had earlier suspended the trial on the use of the drug for the treatment of COVID-19 patients after a study published by The Lancet claimed chloroquine had no positive effect on the treatment of COVID-19 among 96,032 sampled patients.

The study also reported a higher mortality rate among those who used the drug.

But on June 3, the organisation made a U-turn and said it was resuming clinical trial of the drug.

This was after a report revealed that the clinical trial of the drug was suspended based on questionable data.

Tedros Ghebreyesus, the WHO director-general, said findings by the WHO data safety monitoring board revealed that there was no reason to discontinue the trial after reviewing available data on the drug.

Adelowo Adegboyega
Link Up
OduNews on Google News

Submit press release, news tips to us: [email protected] | Follow us @ODUNewsNG